ZSAN Zosano Pharma Corporation

1.33
-0.04  -3%
Previous Close 1.37
Open 1.35
Price To book 1.88
Market Cap 52.14M
Shares 39,200,000
Volume 323,464
Short Ratio 0.44
Av. Daily Volume 1,410,360

SEC filingsSee all SEC filings

  1. 8-K/A [Amend] - Current report 17866783
  2. 10-Q - Quarterly report [Sections 13 or 15(d)] 17827477
  3. 8-K - Current report 17826382
  4. 8-K - Current report 17819553
  5. DEF 14A - Other definitive proxy statements 17796115

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 trial data due released February 13, 2017 - primary endpoints met.
M207
Migraine
Phase 2 data released September 2015. Considering Phase 3 initiation in 2016
ZP-Glucagon
Severe hypoglycemia